Document Detail


Population analysis of ethnicity and first-phase insulin release.
MedLine Citation:
PMID:  20570007     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: A mechanistic, physiologically-based pharmacokinetic (PK/PD) model was developed to describe the biphasic insulin release and evaluate the racial effects on the glucose-insulin kinetics in response to intravenous glucose.
METHODS: Fifteen African-American and 18 Caucasian children and adolescents between 8 and 18 years of age were enrolled in the study. Intravenous bolus of glucose (250 mg/kg) was administered and blood samples collected at frequent intervals for three hours following the glucose injection. A nonlinear mixed-effect population kinetic analysis with covariate structure was performed using Monolix.
RESULTS: A significantly higher initial insulin secretion from a readily releasable pool, which is responsible for the first-phase insulin secretion, was detected in African-Americans compared to Caucasians (p<0.05).
CONCLUSIONS: The proposed kinetic model is able to describe the glucose-stimulated insulin response, account for the first-phase insulin release and identify a racially-based pharmacokinetic difference in insulin's biphasic secretion behavior. It is hypothesized that the first-phase insulin component may play an important role in the development of type 2 diabetes. The proposed mechanistic model provides a quantitative analysis of the biphasic insulin release that may be useful in the early detection of diabetes.
Authors:
Lanyi Xie; Robert P Hoffman; Peter Veng-Pedersen
Related Documents :
6375227 - Effect of pha-b fraction of agaricus bisporus lectin on insulin release and 45ca2+ upta...
8538167 - Glutathione-mediated preservation and enhancement of isolated perifused islet function.
786987 - Stimulus-secretion coupling of glucose-induced insulin release. metabolism of alpha- an...
3294547 - Decreased insulin secretory response of pancreatic islets during culture in the presenc...
1612227 - Contrasting metabolic effects of continuous and pulsatile growth hormone administration...
9771447 - Haemoglobin le lamentin (alpha 20 (b1) his-->gln) in a british family: identification b...
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2010-05-31
Journal Detail:
Title:  Diabetes research and clinical practice     Volume:  89     ISSN:  1872-8227     ISO Abbreviation:  Diabetes Res. Clin. Pract.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-10     Completed Date:  2010-11-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8508335     Medline TA:  Diabetes Res Clin Pract     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  243-9     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
African Americans
Child
European Continental Ancestry Group
Female
Glucose / administration & dosage,  pharmacokinetics*
Humans
Insulin / blood*,  secretion*
Male
Chemical
Reg. No./Substance:
11061-68-0/Insulin; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting growth rates and growth boundary of Listeria monocytogenes - An international validation ...
Next Document:  Obesity, smoking, and cigarette taxes: evidence from the Canadian Community Health Surveys.